yttrium radioisotopes has been researched along with Digestive System Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colquhoun, SD; Friedman, ML; Kim, AS; Nissen, NN; Ozao-Choy, J; Wachsman, A; Wolin, EM; Yu, R | 1 |
| Baete, K; Bogaerts, K; Clement, PM; Deroose, CM; Haustermans, K; Koole, M; Mortelmans, L; Mottaghy, FM; Terwinghe, C; Van Binnebeek, S; Van Cutsem, E; Vanbilloen, B; Verbruggen, A; Verslype, C | 1 |
| de Herder, WW; de Jong, M; Kam, BL; Krenning, EP; Kwekkeboom, DJ; Teunissen, JJ; Valkema, R; van Eijck, CH; van Essen, M | 1 |
1 review(s) available for yttrium radioisotopes and Digestive System Neoplasms
| Article | Year |
|---|---|
Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Combined Modality Therapy; Digestive System Neoplasms; Gallium Radioisotopes; Humans; Indium Radioisotopes; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Organotechnetium Compounds; Peptides, Cyclic; Positron-Emission Tomography; Quality of Life; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Treatment Outcome; Yttrium Radioisotopes | 2010 |
1 trial(s) available for yttrium radioisotopes and Digestive System Neoplasms
| Article | Year |
|---|---|
Individualized dosimetry-based activity reduction of ⁹⁰Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy.
Topics: Adult; Aged; Digestive System Neoplasms; Female; Humans; Kidney; Kidney Function Tests; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Precision Medicine; Radiation Dosage; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Yttrium Radioisotopes | 2014 |
1 other study(ies) available for yttrium radioisotopes and Digestive System Neoplasms
| Article | Year |
|---|---|
Radioembolization for treatment of liver metastases from neuroendocrine tumors: correlation with imaging and biomarkers.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Digestive System Neoplasms; Embolization, Therapeutic; Female; Humans; Intestinal Neoplasms; Kidney Neoplasms; Liver Neoplasms; Male; Microspheres; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Radiography; Retrospective Studies; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2013 |